These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25726939)

  • 1. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
    Silva CY; Goldberg LJ; Mahalingam M; Bhawan J; Wolpowitz D
    J Cutan Pathol; 2011 Oct; 38(10):797-800. PubMed ID: 21812802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Occult Invasion in Melanoma In Situ.
    Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
    JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating neurotized melanocytic nevi from neurofibromas using Melan-A (MART-1) immunohistochemical stain.
    Chen Y; Klonowski PW; Lind AC; Lu D
    Arch Pathol Lab Med; 2012 Jul; 136(7):810-5. PubMed ID: 22742554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
    Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
    J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
    Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
    J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nodal metastases in melanoma using sox-10.
    Jennings C; Kim J
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients With Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature.
    Gonzàlez-Farré M; Ronen S; Keiser E; Prieto VG; Aung PP
    Am J Dermatopathol; 2020 Oct; 42(10):739-744. PubMed ID: 32271206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi.
    Huwait H; Hijazi N; Martinka M; Crawford RI
    Am J Dermatopathol; 2014 Apr; 36(4):340-3. PubMed ID: 24736669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melan-A expression in non-melanocytic carcinoma: A potential diagnostic pitfall.
    Zuo L; You H; Cai Z; Liao S; Lu X; Li L; Huang W
    Histol Histopathol; 2024 Aug; 39(8):1037-1041. PubMed ID: 38205829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.